StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Accrued rebates by Year

Accrued rebates — Medicaid, Medicare & commercial contracting (Current liabilities) ($M) ($M)

Pfizer Accrued rebates: $7,909M in FY2025, up 9.9% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
7,909
Period ended Dec 31, 2025
Change on a year earlier
+9.9%
7,195 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Note 17 — Revenue Deductions & Rebate Accruals.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued rebates — Medicaid, Medicare & commercial contracting (Current liabilities) ($M) ($M)Year on yearSource
FY2025Dec 31, 20257,909+9.9%Form 10-Q (filed 2026-08-04) ↗
FY2024Dec 31, 20247,195+29.7%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 20235,546+23.8%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 20224,479+17.5%Form 10-K (filed 2024-02-22) ↗
FY2021Dec 31, 20213,811+26.3%Form 10-K (filed 2023-02-23) ↗
FY2020Dec 31, 20203,017+20.1%Form 10-K (filed 2022-02-24) ↗
FY2019Dec 31, 20192,512-21.7%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 20183,208+20.0%Form 10-K (filed 2020-02-27) ↗
FY2017Dec 31, 20172,674+18.3%Form 10-K (filed 2019-02-28) ↗
FY2016Dec 31, 20162,261–Form 10-K (filed 2018-02-22) ↗

Cite this data

StockData. (2026). Pfizer Accrued rebates ($M), annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/gtn-cur-rebates

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.